Background: Invasive peak-to-peak pressure gradients are the current clinical reference standard for assessing aortic coarctation. To obtain them, patients need to undergo arterial heart catheterization. Unless an intervention is performed, the procedure remains purely diagnostic, while the concomitant risks remain. Purpose: To validate MRI-based pressure mapping against pressure drop derived from heart catheterization and to define minimal clinical requirements. Study Type: Prospective clinical validation study. Population: Twenty-seven coarctation patients with an indicated heart catheterization were enrolled at two clinical centers. MRI Sequences: 1.5T including 4D velocity-encoded MRI and 3D anatomical imaging of the aorta. Assessment: Pressure drop across the stenosis was calculated by pressure mapping based on the pressure Poisson equation. Calculated pressure drops were compared with catheter measured data. Spatial and temporal resolution were analyzed using in silico phantom-based data as well as in vivo measurements. Statistics: Pressure drop was compared to peak-to-peak measurements. A two-sample paired mean equivalence test was used. Results: In patients without imaging artifacts and a required spatial resolution ≥5 voxel/diameter, significant equivalence of pressure mapping compared to heart catheterization was found (17.5 ± 6.49 vs. 16.6 ± 6.53 mmHg, P < 0.001). Data Conclusion: Pressure mapping provides equivalent accuracy to pressure drop obtained from heart catheterization in patients 1) without previous stenting and 2) with sufficient spatial image resolution (at least 5 voxels/diameter). In these patients the method can reliably be performed prior to the actual procedure, and thus allows safe noninvasive treatment planning based on MRI. Level of Evidence: 2 Technical Efficacy: Stage 3
risks and side effects. These include the use of sedative medication, bleeding, vascular injury with aortic dissection, and death. 2 Unless an intervention is performed the procedure remains diagnostic. In contrast, the European Society of Cardiology (ESC) advocates the use of noninvasive pressure differences between the upper and lower limbs. 3, 4 Despite the lack of uniformity, peripheral blood pressure differences do not assess the transstenotic pressure drop, but pressure differences between peripheral arteries that are naturally prone to anatomic variations, pulse wave reflections, and the measurement setup (eg, cuff size). Echocardiography-based measurements of the transstenotic pressure drop tend to systematically overestimate pressure drop, as using the Bernoulli equation implies unrealistic fluid conditions without considering friction and turbulence. 5 Magnetic resonance imaging (MRI)-based pressure mapping has been developed as a noninvasive technique to assess pressure drop based on blood velocity fields acquired by noninvasive imaging such as 4D flow MRI. [6] [7] [8] Nevertheless, its application to clinical routine remains challenging, as complex experimental simulations are mainly limited to a few engineering departments and require high computing resources. 6 Clinical applicability and diagnostic accuracy of a time-effective solution remains to be demonstrated in CoA patients. In order to achieve these goals, pressure mapping tools need to be validated against clinical reference standards and tested for usability in a realistic target population. The aim of this study was to validate noninvasive pressure mapping against data derived from heart catheterization in patients with CoA, and to define minimal clinical requirements for its applicability.
Materials and Methods

Study Population and Design
In a clinical study cohort, 27 patients (20 males/7 females) were included from two centers. Inclusion criteria were: 1) the presence of CoA, and 2) the requirement to undergo heart catheterization. Exclusion criteria were any contraindications for MRI. Treatment indications were noninvasive or peak-to-peak systolic pressure drop >20 mmHg or the presence of severe stenosis with relevant narrowing and arterial hypertension. Hypertension was defined according to age-specific reference percentiles in pediatric patients 9 and routine classification according to the AHA in adult patients. 10 Baseline characteristics of all patients are summarized in Table 1 . The study was carried out according to the principles of the Declaration of Helsinki and approved by the local Ethics Committees at both centers. Written informed consent was obtained from the participants and/or their guardians. The clinical study has been registered with ClinicalTrials.gov.
MRI Data
MRI in the first center was performed on a whole-body 1.5T Achieva (R 3.2.2.0) MR scanner using a five-element cardiac phased-array coil (Philips Medical System, Best, Netherlands), whereas the second center used a 1.5T Aera system (Siemens, Erlangen, Germany). During MRI flow acquisition, cuff measured pressures of the upper and lower extremities were assessed using Dinamap Pro 300V2 (GE Medical Systems, Milwaukee, WI).
Flow-sensitive 4D velocity-encoded MRI (4D VEC MRI) of the thorax was performed using a 4D segmented k-space phase contrast gradient echo sequence, with retrospective electrocardiographic gating without navigator gating of respiratory motion in order to minimize acquisition time. Sequence parameters were: acquired voxel 2.5 × 2.5 × 2.5 mm, reconstructed voxel 1.7 × 1.7 × 2.5 mm, repetition time 3.5 msec, echo time 2.2 msec, flip angle 5 , 25 reconstructed cardiac phases, number of signal averages 1. High-velocity encoding (3-6 m/s) in all three directions was used in order to avoid phase wraps in the presence of coarctation and associated secondary flow. Scan time varied between 9 and 14 minutes, depending on patient anthropometrics. Flow measurements were completed with automatic correction of concomitant phase errors. 3D anatomical imaging was acquired at end-diastole. The sequence parameters were adapted to patient age and size: acquired voxels by default were 0.66 × 0.66 × 3.2 mm, reconstructed voxels 
Postprocessing and Analysis of Image Data: Pressure Mapping
The processing and analysis pipeline of the pressure mapping is illustrated in Fig. 1 and consists of the following five steps:
1. Semiautomatic segmentation of the aortic domain from 3D MRI with generation of a representative aortic surface mesh. 2. Background phase correction and phase-unwrapping of the 4D VEC MRI data and generation of a sequence of volumetric velocity vector fields. 3. Interactive registration of the aortic surface and the velocity fields. Generation of implicit representation of the aortic surface by creating a level set on the velocity regular grid. 4. Solution of the pressure Poisson equation (PPE) onto a subdomain of the lumen at each time step. Generation of a sequence of volumetric data containing relative pressures. 5. Statistical analysis of the relative pressures in the ascending aorta (P1) and in the descending aorta (P2) and computation of the time-varying pressure drop between P1 and P2 as the difference between the mean pressure values at a given time-step in the respective regions.
In the first step, semiautomatic segmentation of the aorta from 3D MRI data was performed, as 3D data yields better spatial resolution than 4D VEC MRI. The outcome of the segmentation is the patient-specific aortic surface mesh, ie, a geometric representation of the patient's aorta anatomy (inner vessel surface) at end-diastole, which is later used to define the computational domain of the PPE solver in the 4D VEC MRI data.
In the second step, the 4D VEC MRI velocity fields are corrected. Acquired velocity fields can contain noise artifacts from multiple sources, which can be mitigated through the use of various denoising or enhancement algorithms. In order to minimize occurrences of extra artifacts that could be introduced by such algorithms, especially in unresolved thin vessel regions such as stenotic or thin supra-aortic arteries, we keep them at a minimum. Therefore, we only use background phase correction for the velocity fields, followed by phase-unwrapping, 11 such that possible velocity aliasing artifacts are minimized. In the third step, the 3D position of the MRI-derived aortic mesh (see first step) is interactively adjusted for enhanced alignment with the velocity fields. Moreover, in order to avoid partial-volumeinduced artifacts near the aortic wall, as well as to minimize the possible mismatch between the fixed aortic mesh and the deforming aortic domain defined by the velocities, we uniformly shrink the aortic domain by the smallest data grid size dx. This is done by computing an implicit representation of the surface mesh in the form of a signed distance function (with positive sign inside the lumen), and by restricting the computational domain to be the region above the dx level (Fig. 2, left panel) .
In step four, the PPE with Neumann boundary conditions is solved using the formulation for relative pressure computation presented previously. 12 The regular grid discretization uses a finite volume formulation with the pressure defined at the cell centers, and velocity components defined at face centers, as proposed previously. 13 This provides an elegant and accurate face area-weighted discretization of the PPE, which generates a linear system that is solved using a GPU-accelerated implementation of the preconditioned conjugate gradient method. A usual dataset with a time-resolution of about 25 frames per heartbeat is fully processed in less than 2 minutes on a standard workstation (Intel Xeon 2.6 GHz, 8GB RAM, NVidia Quadro K2000). The output is a sequence of 3D relative pressure fields, one for each time-step of the 4D VEC MRI data. Finally, in step five the pressure drop between predefined catheter measurement locations in the ascending (P1) and descending (P2) aorta is computed based on the relative pressure fields, as illustrated in Fig. 1 . Instead of fixed measurement points, in heart catheterization the exact location of the pressure sensor is not known, as the blood stream can cause the catheter to move during acquisition. In order to enable proper validation of pressure mapping against invasive catheter data, we defined spherical regions of interest ( Fig. 2 , right panel) for sampling the data.
This process digitally imitates pigtail catheters used during heart catheterization. Those usually have a set of holes over a length of 20 mm and thus measure volume-averaged pressure signals. For each region, we stochastically aggregate the relative pressure samples to estimate not only the most likely pressure drop measured by the catheter, but also an "uncertainty margin" (lower and upper bounds) to account for errors due to the uncertain catheter location. The most likely pressure drop is computed by subtracting the mean of all relative pressure samples in P2 from the mean in P1: mean(P1) -mean(P2). The lower bound is computed as min(P1) -max(P2), and the upper bound as max(P1) -min(P2). This gives a range of potential pressure drop values the catheter may have measured. Based on these data we quantified the uncertainty of the pressure drop assessment by pressure mapping due to the unknown exact position of the catheter based measurements.
Pressure Mapping Resolution Analysis
Pressure mapping is a finite volume method with requirements on the space discretization as any discretization method. In order to find limitations for the spatial resolution, an in silico phantom-based analysis was performed. The experiment was based on in silico phantom data (geometry and velocity field) of a stenosis model described earlier, 14 since the stenosis region is the most critical for the resolu- Original velocity field data were downsampled to resolutions of 2, 3, 4, and 5 mm and the pressure mapping algorithm calculated pressure drop at each resolution level. 3D anatomical imaging data of all patients were analyzed in order to quantify the spatial resolution of the stenotic region in our study cohort and to include an impact of noise and imaging artifacts.
Furthermore, the impact of the temporal resolution (phase duration) was analyzed, as phase averaging during MRI acquisition could result in an underestimation of velocity magnitudes during peak systolic flow conditions. Ten patient-specific flow rate curves of the aortic flow acquired with high temporal resolution (100 phases) by 2D VEC MRI were downsampled to quantify the decrease of the maximal flow rate due to averaging with a larger phase period. Finally, the patient-specific 4D VEC MRI data were processed (all velocity components were continuously reduced by a constant relative value) and adapted velocity data were propagated in the pressure mapping solver. This is done in order to quantify the bias of the pressure drop assessment due to the bias of the MRI-based velocity field assessment.
Validation and Statistical Analysis
Validation was performed using a two-sample paired mean equivalence test. 15 The null hypothesis in this test assumes that measurements between methods (pressure mapping and catheter measurements) differ considering a set clinical threshold (8.0 mmHg). Its rejection leads to acceptance of the alternative hypothesis (equivalence) and results in significant P-values. The threshold was defined based on the standard deviation (SD) of pigtail catheter measurements. Linear regression was used to assess the correlation between the degree of stenosis and the flow ratio. Measured data are presented as mean and SD unless stated otherwise. All data were tested for normality using the Kolmogorov-Smirnov test. STATA v. 15.1 (StataCorp, College Station, TX) was used for statistical analysis. P < 0.05 was considered significant.
Results
The minimal spatial resolution requirements to assess the stenosis of the in silico phantom (computational experiment) are illustrated in Fig. 3 . Pressure drop assessment in the in silico phantom was accurate down to a voxel size of 3 mm, resulting in a minimal spatial resolution of 3.4 voxel per crosssectional diameter of the stenosis. The method underestimated pressure drop by 20% at a voxel size of 4 mm (corresponding to a spatial resolution of 2.6 voxel per diameter) and fully failed in lower resolutions (5 mm voxel size). The temporal resolution analysis based on downsampled high-resolution (100 phases) VEC-MRI found that 25 phases (as used during 4D VEC MRI) resulted in a measurement error (decrease) of averaged flow rates and resulting velocities of 3.5 ± 2.27%. Applying this information to the pressure mapping algorithm, the decreased velocity magnitudes resulted in a linearly dependent decrease of the calculated pressure drop by a factor two. Velocity reduction by 3.5% results in a pressure drop reduction of 7%. The linear dependence of this relationship was investigated up to 6% of velocity reduction.
In the clinical setting the spatial resolution was further analyzed in 27 CoA patients with an age range between 7 and 58 years (mean and SD: 20 ± 13.2 years). In order to assess the minimal resolution requirements in clinical imaging data patients were identified where the spatial resolution was near the minimal threshold of the phantom (3.4 ± 0.64 voxels/ diameter; N = 7). Pressure mapping in these cases resulted in a systematic underestimation of the pressure drop without significant equivalence (8.5 ± 5.19 mmHg vs. 42.6 ± 4.75 mmHg, P = 0.999). Furthermore, previously stented patients were identified, where imaging artifacts affected flow measurements in the stenotic region (N = 4). Pressure mapping in stented patients resulted in systematic underestimation of calculated pressure drop and failure to prove equivalence (10.1 ± 2.3 vs. 19.5 ± 4.1 mmHg, P = 0.736). Figure 4 illustrates the systematic pressure drop underestimation in patients with low resolution (LR) and previous stenting (S).
When applying minimal image quality (artifact-free stenotic region) and resolution requirements, including a safety margin based on 1.96 SDs (identical to the 95% confidence interval; 2.15-4.65 voxel/diameter) of >5 voxel per diameter application of pressure mapping resulted in significant equivalence between pressure Poisson and catheter-based pressure drop (two-sample paired mean equivalence test, 17.5 ± 6.53 vs. 16.6 ± 6.49 mmHg, P < 0.001) in N = 16 patients. The differences between pressure drop predicted by the pressure Poisson method and the actual peak-to-peak pressure drop are visualized in a Bland-Altman plot (Fig. 5) .
In the entire patient cohort (N = 27), no significant differences in pressure mapping success rates were found between both clinical centers. A significant linear correlation of the flow ratio to the descending aorta and the degree of the stenosis was found (P < 0.001, R 2 = 0.3). The results are illustrated in the table in Fig. 6 .
Uncertainty Analysis
The averaged lower bound of the uncertainty margin in the whole cohort (N = 27) was 8.5 ± 5.70 mmHg, whereas the averaged upper bound of the uncertainty margin was 20.8 ± 9.07 mmHg. In 16 of 27 cases (59%) the cathetermeasured pressure drop was inside the uncertainty margin of the PPE approach. Considering only the N = 16 cases with sufficient flow (>30%) to the descending aorta and sufficient image quality (cases without metal artifacts), the averaged lower bound of the uncertainty margin was 11.1 ± 5.10 mmHg, whereas the averaged upper bound of the uncertainty margin was 25.5 ± 8.29 mmHg. In this cohort of cases the clinically measured pressure drop was within the uncertainty margin in 87.5% of cases. All cases with low flow were out of the uncertainty margin, whereas two of four cases with stent artifacts were within the margin. The threshold for the sufficient flow with 30% is based on the performed receiver operating curve (ROC) analysis for the correct pressure drop prediction by pressure mapping: at the cutpoint of 29.5%, the true-positive rate was 0.929 by false-positive rate of 0.333, whereas at the cutpoint of 31.5% the true-positive rate was 0.929 by false-positive rate of 0.222 and the true-positive rate of 0.857 by false-positive rate of 0.222 at the cutpoint of 34.0%. Yielding minimal resolution requirements allows pressure mapping to be used in a broad range of clinical scenarios. Even if the diameter of the stenosis is small (eg, in infants), this allows imaging teams to adapt the spatial resolution during MRI acquisition in order to achieve the additional benefit of noninvasive therapy planning. Recognizing patients with previous stenting can help to avoid additional acquisition time in patients where artifacts in 4D VEC MRI, namely, a marked loss of signal in the previously stented coarctation region, are associated with systematic underestimation of the pressure drop. Alternatively, pressure drop can still be assessed noninvasively in those patients where pressure mapping is not available using earlier validated computational fluid dynamics (CFD) 17 approaches that are solely based on the geometry and proper inflow profiles. Such simulations are usually more time-and resource-intensive, as CFD requires high spatial (mesh) resolutions and the integration of turbulence models as well as fluid-structure interaction when vascular properties are required. In contrast, pressure mapping is based on quickly acquired velocity fields and contains all physiological phenomena including pressure wave propagation due to wall elasticity, turbulence, and blood fluid behavior. Nevertheless, CFD or pressure mapping may not be necessary in patients where clinical guidelines already recommend treatment due to a high degree of stenosis (>50%). Such assessments can be easily made based on the flow ratio between the descending and the ascending aorta and may already provide a Class II / Level C treatment indication. 1, 3, 4 Figure 6 summarizes the existing diagnostic options with the focus on a time-effective noninvasive diagnostic process, and based on the results of our study as well as previous CFDbased validation studies. 17 The present study demonstrates the clinical usefulness, limitations, and the accuracy of pressure mapping and strategies for its clinical application. The method is still limited to centers where the diagnostic tools are available. Noninvasive diagnostic options can, however, motivate specialized clinical centers to use available methods to avoid the risk of invasiveness wherever possible. Benefiting patients can already be selected based on the screening algorithm shown in Fig. 6 . While in cases with metal artifacts due to previous stenting, MRI-based assessment can still be useful for anatomical imaging (using black blood sequences to suppress metal artifacts) and the indirect assessment of the stenosis (based on the flow ratio), other methods for pressure drop assessment (CFD) are required. Pressure mapping based on 4D VEC MRI with a fixed spatial resolution resulted in systematic underestimations of the current method in patients with a higher degree of stenosis or a small vasculature. Clinicians and technicians need to be aware of these limitations and can prevent them by choosing the right voxel size.
Power Calculation
In patients with inadequately low resolution, flow rates to the descending aorta (19 ± 9.4%) were considerably lower than previously published flow rates in CoA patients with 46.7 ± 16.4% and in healthy controls with 67.7 ± 12.6%. 18 It was further demonstrated that the low flow cases were associated with a high degree of stenosis (cross-sectional area in percentage reduced by the stenosis: 77.1 ± 5.64%) as well as a formation of collateral vessels. In all "low flow" patients there was a clinical treatment indication according clinical guidelines, as all were associated with a higher degree of stenosis. 1, 2 While pressure mapping may be of interest, it is not crucial in order to make clinical decisions in patients where flow distribution is already pointing at a higher degree of stenosis. Most pressure mapping approaches involve two main steps. First, the velocity fields need to be reconstructed, which can be challenging due to issues related to the limited quality of 4D VEC MRI data. 12, 19 In order to tackle this problem, the MRI raw data needs to be enhanced to enforce physical properties such as the mass conservation of an incompressible fluid. 12, 20 In a second step, the pressure map is computed from the filtered velocity vector field. To this end, the pressure Poisson equation (PPE) is being solved, 12,21 which can be done efficiently in only a few seconds if implemented on modern hardware. Errors from various sources can influence the quality of the pressure drop as computed by the PPE algorithm. They can be data-, algorithmic-, or analytics-related, and each of them is being mitigated in order to reduce its influence on the final result.
Data-related limitations and solutions include:
• 4D VEC MRI data errors are first corrected for background phase variation by subtraction of best-fit linear space to the static tissue manifold and phase-unwrapped by optimizing a temporal smoothness measure of each velocity component.
• Coarctation cases, as opposed to healthy ones or data from a simplified in silico phantom-based model, do not allow effective use of velocity magnitudes for lumen segmentation due to the strong post-coarctation jet that biases the signal unfavorably; this is mitigated through the use of higherresolution MRI angiography data for segmentation; this requires additionally an interactive registration in order to mitigate the misalignment of MRI angiography and 4D VEC MRI data; this could be further enhanced through automatic registration optimization techniques.
• Partial volume effects due to averaging of different tissue signal responses are known to reduce velocity reconstruction quality near the vessel walls; therefore, for example, the physical no-slip boundary condition controlling fluid-flow does not hold anymore, and the boundary conditions for PPE could not be applied using the luminal velocity. Our algorithm addresses this with a geometric domain reduction ("erosion") by the minimum image resolution, which ensures a marked enhancement of the PPE solution accuracy.
Algorithmic-related limitations include:
• Interpolation errors of input velocity data; due to the PC-MRI reconstruction errors present in the velocity field, we use only first-order accurate interpolation kernels that do not magnify discontinuities; linear interpolation is such an operator that was here being used for resampling the raw velocity data using a staggered grid. 12 This constrains the approximation accuracy of the velocity input to be at most O(dx) in the grid resolution dx. While this implies an approximation accuracy of at most O(dx
) for the viscous terms, for aortic flow these terms can be safely ignored, as the inertial terms are highly dominant. A slope-limited higher-order interpolation kernel will be tested in future work.
• While the accuracy of the PPE solution for the considered discretization was shown in Ref. 13 to be O(dx 2 ) in both the max and the Manhattan norms for analytic velocities, this may of course be reduced by the specific accuracy of the velocity input.
Analysis-related limitations and solutions include: the spatial uncertainty of pressure catheter location can lead to large variations in the measurements, especially for coarctation cases, in which the radial pressure variations are much larger than in normal patients; variations as large as 20 mmHg were observed in the aortic arch, and even ascending aortic radial variations of more than 10 mmHg. Our solution mitigates the influence of the spatial uncertainty by using solid spherical domain averages around the specified catheter probe locations, while concurrently offering uncertainty margins that may find clinical use.
The noninvasive assessment of transstenotic pressure drop 6 and flow distribution 18 prior to heart catheterization has been previously described in patients with aortic coarctation. Our study adds a clinical validation of pressure drop based on pressure mapping computation against current clinical reference standards, as well as the proposed workflow to integrate the method in diagnostic approaches. While ESC and ACC/AHA guidelines 1, 4 are primarily based on pressure drop, in the last decades the overall concept of the disease's pathophysiology has changed from that of a simple obstruction to a more systemic illness that involves 1) baroreceptor dysfunction, 22 2) vascular dysfunction, 23 and 3) adverse myocardial remodeling. 24, 25 It remains unclear if pressure drop should be the main focus of intervention if a majority of patients with aortic coarctation remain hypertensive even years after removing a relevant narrowing and cardiovascular events are frequent. 26 Nevertheless, current treatment strategies can be effective 27 : especially in combination with well-planned interventions that reduce reintervention rates, they can potentially lower some risks for CoA patients and may allow reducing antihypertensive medication. 28, 29 Further research is needed to address these problems in future clinical trials that focus on longer-term outcomes.
Pressure mapping can provide model-based decision support in patients with aortic coarctation, providing that MRI data are free of metal artifacts and adequate spacial resolutions are used. It should be used in combination with flow measurements not only to improve its accuracy but to identify those patients with treatment indications due to higherdegree stenosis and significant collateral flow. Especially in borderline cases with pressure drop near treatment thresholds, the accurate estimation of peak-to-peak pressure drop can help to avoid unnecessary diagnostic heart catheterization with all its associated risks and costs. It allows clinicians to personalize therapy planning and select those patients with a clear treatment indication before an invasive interventional or surgical procedure is performed.
